Keyphrases
Recombinant
100%
Respiratory Syncytial Virus
100%
Chimpanzee
100%
Virus
50%
Vaccine Candidate
33%
Upper Respiratory Tract
33%
Immunogenicity
16%
Attenuation
16%
Virus Strains
16%
Elderly People
16%
Respiratory Syncytial Virus Vaccines
16%
Lower Respiratory Tract
16%
Rhinorrhea
16%
Recombinant Virus
16%
Pediatric Population
16%
Recombinant Form
16%
Attenuating mutations
16%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Wild Type
50%
Upper Respiratory Tract
33%
Immunogenicity
16%
Lower Respiratory Tract
16%
Respiratory Syncytial Virus Vaccine
16%
Recombinant Virus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
100%
Respiratory Tract
50%
Immunogenicity
16%
Respiratory Syncytial Virus Vaccine
16%
Rhinorrhea
16%
Biochemistry, Genetics and Molecular Biology
Human Respiratory Syncytial Virus
100%
Wild Type
42%
Immunogenicity
14%
Virus Recombinant
14%